Aim-To prepare a monoclonal antibody (EB9) against the trophozoite form of Pneumocystis carinii and to test its efficacy for detecting infection with this organism. Method-The sensitivity and specificity of the EB9 antibody were assessed by comparing it with other conventional stains (Papanicolaou, Giemsa and Grocott) and 3F6 antibody in 33 bronchoalveolar lavage specimens from HIV positive patients suspected of having P carinii pneumoma.
in 15 of 33 patients. In 14 cases the organism was detected by two or more of the staining methods used; however, EB9 failed to detect infection in two cases which were positive by other staining techniques. In one case P carinii infection was detected by EB9 only. Conclusion-The results of this study suggest that P carinii infection in the lung may occur in two forms: the cyst form and the trophozoite form, which may explain the observed variation in response to treatment. (7 Clin Pathol 1994 ;47:1108-1 11 1) In a recent study a group of patients who were negative when tested for Pneumocystis carinii infection on routine cytological staining of bronchoalveolar lavage (BAL) specimens with Papanicolaou, Giemsa, Grocott, and 3F6 monoclonal antibody nevertheless showed a clinical response to treatment for this infection. ' This may have been because the staining methods used to detect the cysts were not sensitive enough. An alternative explanation is that these cases may represent infection with the trophozoite form of P carinii, which cannot be detected by the above staining methods.2 To prove the latter hypothesis, trophozoites must be detected in BAL specimens. Therefore, to test this hypothesis, a monoclonal antibody (EB9) was raised against P carinii trophozoites and its sensitivity and specificity assessed by comparing it with the conventional stains mentioned earlier.
Methods
Patients included in this study were attending the AIDS clinic at St Mary's Hospital, London. They presented with an episode of infection characterised by cough, shortness of breath, fever or night sweats, interstitial shadowing on chest radiography, hypoxia, and a low or deteriorating transfer factor on lung function testing.
For each patient, a provisional clinical diagnosis was recorded. One BAL specimen was obtained from each patient.
The monoclonal antibody (EB9) was prepared as follows: BAL specimens from patients with P carinii pneumonia were concentrated by centrifugation. P carinii organisms, including cysts and trophozoites, were then separated from host cells using a Percoll gradient method. An isotonic Percoll solution (90%) was prepared by mixing nine volumes of Percoll with one volume of 10 x concentrated phosphate buffered saline (PBS). Four Percoll solutions of different concentrations were prepared by diluting eight, seven, six, and five volumes of 90% isotonic Percoll solution in two, three, four, and five volumes of PBS (pH 7 4), respectively, giving 80, 70, 60, and 50% solutions. Percoll solutions were layered in a 15 ml graduated test tube (Falcon), with the heaviest density (80%) solution (4 ml) at the bottom and the lightest (50%) solution (2 ml) at the top.
A 1 ml cell suspension from a BAL specimen was placed on the top of gradient and centrifuged at 400 x g for 20 minutes. Following centrifugation, cell fractions at different Percoll layers were collected carefully in 5 ml test tubes and washed three times in PBS (pH 7 4) to remove the Percoll. Smears were prepared from the cell pellet from each Percoll layer, and stained using Giemsa to identify the layer containing P carinii cysts and trophozoites. Stained material was mounted in DPX and analysed using light microscopy (Leitz) with x 10 and x 40 objectives.
P carinii organisms were found most frequently in the 50% Percoll solution layer. Lymphocytes and polymorphs were found in the 70% Percoll solution layer. Macrophages and red blood cells were observed in the heaviest layer (80% solution). This procedure was repeated using BAL specimens from cases known to be positive for P carinii infection. The organisms were isolated and resuspended in PBS. P carinii trophozoites and cysts were then separated using Dynabeads (electromagnetic beads).
The cell suspension was sonicated and incubated for 45 minutes at room temperature with a 1 in 50 dilution of 3F6 monoclonal antibody. Following incubation, the cell suspension was washed three times in EB9for the detection ofP carinii trophozoites Figure 1 Immunogold labelled (arrow) trophozoite ofP carinii using the EB9 monoclonal antibody on scanning electron microscopy (magnification X 33 500).
PBS and was then incubated with Dynabeads which had been coated with rabbit antimouse antibody for 45 minutes at room temperature. After application of a magnetic Dynabeads applicator, the remaining cell suspension was aspirated with a glass pipette, spread on Thermanox cover slips, and wet fixed in 2% glutaraldehyde. The trophozoites were visualised using scanning electron microscopy ( fig 1) . antibody; in the remaining case infection was detected with the EB9 antibody only. None of the 18 patients who were negative for P carinii on all staining methods responded to treatment with intravenous co-trimoxazole. Culture was positive for Mycobacterium tuberculosis in three cases, for Haemophilus influenzae in two, for Streptococcus in five, for Staphylococcus in one, and for both Streptococcus and H influenzae in one. Pulmonary Kaposi's sarcoma was detected in one case on histological examination. In six cases culture for M tuberculosis was not performed.
Discussion
The trophozoites of P carinii are 2-4 ,um in length, and appear as unicellular structures with a thin wall and numerous surface projections known as membranotubular extensions on electron microscopy.5 On Giemsa stained smears, trophozoites may appear as tiny specks with no further characterisation. Immunocytochemical evaluation, therefore, was mandatory. On smears stained with the EB9 monoclonal antibody, trophozoites appear as pleomorphic, small, thin walled structures connected to each other by thin membranes (fig 2) .
Isolation and separation of P carinii trophozoites from the cystic form and host cells in BAL specimens is an important prerequisite for the preparation of murine monoclonal antibodies directed specifically against trophozoites. As yet, no technique has been described for complete separation of the trophozoite and cystic forms of P carinii. Many authors, however, have attempted to separate cysts from host cells. In 1986 Kovacs et at6 separated P carinii cysts from lung cells using a Percoll gradient. Taylor and Easmon7 described another method for the separation of P carinii cysts from rat lung tissue homogenates using a unit gravity sedimentation chamber.
In this study, however, a discontinuous Percoll gradient was used in preference to the unit gravity sedimentation chamber for the initial separation of P carinii from host cells for the following reasons. The initial cost of the unit gravity sedimentation chamber is very high, separation is incomplete, and the method is very time consuming. The problem of purification and identification of the gradient layer containing P carinii was resolved by centrifuging the gradient at various speeds until a high level of purification was achieved.
EB9 was specific for the trophozoite form of P carinii. It also reacted with alveolar macrophages in smears from BAL specimens containing P carinii suggesting that EB9 can detect phagocytosed trophozoites. Evidence for this has been provided by the in vitro studies of Von Behren and Pesanti8 who showed that P carinii can be phatocytosed by macrophages. Pfitzer et al9 described inclusions in alveolar macrophages, interpreted as ingested pneumocysts, on fluorescence microscopy of Papanicolaou stained smears from BAL specimens.
The sensitivity of EB9 was determined by comparing the staining pattern with response to treatment and was found to be 86-7%. EB9 was 6-6% less sensitive than 3F6 and the other conventional stains.
In routine clinical practice a combination of EB9 and 3F6 or EB9 alone may be more effective for detecting P carinii trophozoites than staining by conventional methods. Based on the results presented here, we suggest that P carinii pneumonia may present as one of two forms: one in which the cysts predominate, while trophozoites predominate in the other. This could explain why some cases suspected of having P carinii pneumonia are negative for the cyst form on conventional staining, but respond to treatment with co-trimoxazole. This is in accordance with the life cycle of P carinii. In the rat cysts predominate under adverse conditions such as those in the immunocompetent host, whereas trophozoites predominate when conditions are more favourable-that is, in the immunodeficient host. 
